A pioneering direct-to-consumer supplement company operates within the prostate and urinary health sector, offering a unique 2-in-1 softgel combining pumpkin seed oil and saw palmetto. Launched in April 2025, the company achieved $2.96M in revenue over 12 months using a lean dropshipping model. With a primary focus on the U.S. market, this business captures 94% of its revenue there, using Meta Ads as a major revenue driver, supported by ongoing creative testing. Its hero product boasts an impressive ~80% gross margin and maintains a 25% net profit margin. The company’s business model benefits from 53% recurring revenue, with notable opportunities in under-utilized email and SMS lists. Growth avenues include transitioning to U.S.-based fulfillment to reduce churn due to long shipping times, launching on Amazon, optimizing subscription funnels, and expanding the product line. The company’s manageable operating expenses and ~29% monthly churn represent current challenges yet provide opportunities for strategic improvement. The founder is looking to sell the business, priced at $1.22M, to focus on other ventures and will offer six months of transition support. Key assets included in the sale are the Shopify store, brand assets, Meta ad accounts, and existing supplier relationships. The founder commits to a non-compete agreement within the pumpkin seed oil/prostate health category. The business is positioned attractively with no debt, near-zero working capital needs, and clear growth levers such as domestic fulfillment and enhanced digital marketing strategies.